JJGC S.A.

Manufacturer adverse-event records for JJGC S.A. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2020–2026 · heavy-book · quiet Death-code · injury-heavy

Death-code intensity

JJGC S.A. is quieter on Death-coded events

Death-coded event_type rows are 0 of 193,729 (0.00% · quiet tercile among 443 manufacturers). Absolute volume is heavy-book.

What the Death-code reading shows for JJGC S.A.

The standout signal for JJGC S.A. is Death-code intensity: 0.00% of 193,729 reports (quiet tercile), while absolute volume is heavy-book.

As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair JJGC S.A. with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.

Reports span 4 device types, led in this extract by Injury at 193,729 (100.0% of event_type total). Peak single-year volume reaches 61,653 reports across 7 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

193,729
Total Reports
0
Event-type Death
193,729
Injury Reports
4
Device Types

Event Types

Injury 193,729 (100.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 193,266 (99.9%)
R 126 (0.1%)

Yearly Trend

20
2020: 4,421
21
2021: 11,246
22
2022: 24,070
23
2023: 32,202
24
2024: 48,461
25
2025: 61,653
26
2026: 11,676